Literature DB >> 8544403

Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS.

W A Nockher1, J E Scherberich.   

Abstract

Expression of CD14 on peripheral blood monocytes and serum levels of the 53 kD soluble CD14 antigen were investigated in patients with end-stage renal failure who were undergoing chronic hemodialysis (HD) with either cuprophane/hemophane (CU/HE) low-flux (LF) or polysulfone/polyamide (PS/PA) high-flux (HF) membranes. Baseline expression of CD14 was significantly lower in HD patients compared to uremic patients and normal controls. Patients using PS/PA membranes disclosed a further decreased CD14 expression than patients with CU/HE membranes. Specific fluorescence intensity for CD14 increased 15 minutes after the start of the dialysis session and was on average 22% higher after hemodialysis. The serum levels of sCD14 were elevated about 2.5-fold in HD patients compared to healthy controls (5.4 +/- 1.3 vs. 2.2 +/- 0.5 mg/liter, P < 0.0001) and were significantly higher compared to non-dialyzed patients with chronic renal failure (3.9 +/- 1.0 mg/liter, P < 0.001). After regular dialysis with high-flux membranes, soluble CD14 serum concentrations significantly increased (P < 0.001) compared to pre-dialysis levels. Values of soluble CD8 (54 kD) were elevated only 1.5-fold in HD patients relative to healthy controls, whereas serum levels of the low molecular weight soluble CD23 (20 kD) 12 and 19-fold in patients treated with HF-HD and LF-HD, reflecting the renal impairment and filtration through HF membranes. Thus, high sCD14 values in HD patients may stem from increased release of the up-regulated membrane antigen due to monocyte activation during hemodialysis treatment. Since the CD14 antigen is involved in LPS-induced monocyte activation, the influence of lipopolysaccharide on CD14 expression and sCD14 release was investigated in vitro. Addition of 1 ng/ml or 0.01 ng/ml LPS to whole blood significantly enhanced monocyte CD14 expression after 30 or 60 minutes of incubation. The release of soluble CD14 by cultured peripheral blood monocytes significantly increased in the presence of 0.01 ng/ml LPS during a five-day incubation experiment. Our results demonstrate an enhanced expression of CD14 by monocytes after HD and increased sCD14 serum levels possibly due to chronic exposure to trace amounts of endotoxins, as supported by in vitro experiments.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8544403     DOI: 10.1038/ki.1995.436

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Changes in presepsin concentrations in surgical patients with end-stage kidney disease undergoing living kidney transplantation: a pilot study.

Authors:  Junichi Saito; Eiji Hashiba; Tetsuya Kushikata; Akio Mikami; Kazuyoshi Hirota
Journal:  J Anesth       Date:  2015-08-15       Impact factor: 2.078

2.  Olmesartan protects endothelial cells against oxidative stress-mediated cellular injury.

Authors:  Daisuke Kadowaki; Makoto Anraku; Moe Sakaya; Sumio Hirata; Toru Maruyama; Masaki Otagiri
Journal:  Clin Exp Nephrol       Date:  2015-04-23       Impact factor: 2.801

3.  Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.

Authors:  Ruben Poesen; Ali Ramezani; Kathleen Claes; Patrick Augustijns; Dirk Kuypers; Ian R Barrows; Jagadeesan Muralidharan; Pieter Evenepoel; Björn Meijers; Dominic S Raj
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-07       Impact factor: 8.237

4.  Increased levels of soluble CD14 in sera of periodontitis patients.

Authors:  J Hayashi; T Masaka; I Ishikawa
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

5.  Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis.

Authors:  W A Nockher; J E Scherberich
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  Differences in Toll-like receptor expression and cytokine production after stimulation with heat-killed Gram-positive and Gram-negative bacteria.

Authors:  O Beran; R Potměšil; M Holub
Journal:  Folia Microbiol (Praha)       Date:  2011-06-15       Impact factor: 2.099

7.  Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients.

Authors:  Juan F Navarro-González; Carmen Mora-Fernández; Mercedes Muros de Fuentes; Javier Donate-Correa; Violeta Cazaña-Pérez; Javier García-Pérez
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

8.  Differences in Toll-like receptor expression and cytokine production after stimulation with heat-killed gram-positive and gram-negative bacteria.

Authors:  Ondřej Beran; Roman Potměšil; Michal Holub
Journal:  Folia Microbiol (Praha)       Date:  2011-03-12       Impact factor: 2.099

9.  Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis.

Authors:  Dominic S C Raj; Vallabh O Shah; Mehdi Rambod; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2009-08-20       Impact factor: 8.860

10.  Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.

Authors:  Dominic S C Raj; Juan J Carrero; Vallabh O Shah; Abdul R Qureshi; Peter Bárány; Olof Heimbürger; Bengt Lindholm; Jennet Ferguson; Pope L Moseley; Peter Stenvinkel
Journal:  Am J Kidney Dis       Date:  2009-09-06       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.